{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-008536","form_type":"8-K","ticker":"GERN","cik":"0000886744","company_name":"GERON CORP","filed_at":"2024-01-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.151508+00:00","generated_at":"2026-06-06T15:34:37.737276+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"FDA schedules advisory committee meeting for Geron's imetelstat NDA on March 14, 2024","bullets":["FDA's Oncologic Drugs Advisory Committee will review imetelstat for transfusion-dependent anemia in lower-risk MDS on March 14, 2024.","Meeting is scheduled from 9:30 a.m. to 3:00 p.m. ET, and will be open to the public.","PDUFA action date for the NDA remains June 16, 2024.","Federal Register notice published January 30, 2024 provides details of the advisory committee meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-008536","json":"https://secwatch.observer/filing/0000950170-24-008536.json","markdown":"https://secwatch.observer/filing/0000950170-24-008536.md","text":"https://secwatch.observer/filing/0000950170-24-008536.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/886744/000095017024008536/0000950170-24-008536-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/886744/000095017024008536/gern-20240130.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T15:34:37.737276+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}